Effectiveness and safety of the hair loss restraint by scalp cooling enforcement addition in the breast cancer chemotherapy
Not Applicable
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000035066
- Lead Sponsor
- ippon Medical School Hospital Breast Surgical Oncorogy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have malignant blood disease or scalp tumor or cold urticaria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary efficacy endpoints are successful hair preservation assessed using the CTCAE4.0scale at the end of 8 cycles of chemotherapy by a clinician unaware of treatment assignment, and device safety.
- Secondary Outcome Measures
Name Time Method